Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - TOTAL EQUITY
Total Equity REGN - Regeneron Pharmaceuticals, Inc.
26 B
LAST VALUE
17.64%
2 YEAR CAGR
24.29%
5 YEAR CAGR
29.54%
10 YEAR CAGR